Dr Ross Walker talks about another new trial into treating Glioblastoma, one of the most aggressive brain cancers.

Peter Switzer and Paul Rickard take a look back on what happened to dividends in 2020 and what is likely to happen in 2021.

Peter Switzer and Paul Rickard look at the potential replacements to JobKeeper, why Wall Street likes Joe Biden and what JB Hi-Fi's strong sales numbers mean for the economy.

Peter Switzer speaks to the founder and CEO of Oventus (OVN), Dr Chris Hart.

On this week's show, Peter Switzer is joined by Fairmont Equities' Michael Gable, Burman Invest's Julia Lee, Switzer's Paul Rickard and Avecho's Dr Paul Gavin.

Peter Switzer is joined by Brian Ward, the founder and CEO of soft tissue regeneration company Aroa (ARX).

Dr Ross Walker explains two studies that are finding new treatments for Glioblastoma, one of the most devastating kinds of brain tumour.

IntelliHR CEO Rob Bromage speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020.

Peter and Paul take a look back on 2020 and look ahead to the stocks that will do well in 2021, plus highlights from an interview with technology entrepreneur Bevan Slattery.

Medlab Clinical CEO Dr Sean Hall speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020.

Prescient Therapeutics CEO Steven Yatomi-Clarke speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020.

Noxopharm CEO Dr Graham Kelly speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020.